PRVAPrivia Health Group, Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−8% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −8% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 10% since the previous count, up from 2.3% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PRVA is trading
Privia Health Group, Inc. is −6.8% over the past year while the S&P 500 is +18%: 25 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −8.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 70
RSI (14) · neutral
- Below its 52-week high
- 26%
Below its 52-week high
Details›
- Last close2026-10-09
- $20.85
- 1 monthS&P 500 +2.7%
- +2.4%
- 1 yearS&P 500 +18%
- −6.8%
- 5 yearsS&P 500 +88%
- −22%
- vs 50-day average$21.03
- −0.88%
- 52-week high
- $28.09
- 52-week low
- $19.11
- Annualised volatility
- 35%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$77K
| Year | Return |
|---|---|
| 2026 (year to date) | −12% |
| 2025 | +21% |
| 2024 | −15% |
| 2023 | +1.4% |
| 2022 | −12% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 2 of 5 | +0.74% |
| Feb | 5 | 5 of 5 | +9.3% |
| Mar | 5 | 1 of 5 | −6.6% |
| Apr | 5 | 3 of 5 | +0.33% |
| May | 6 | 1 of 6 | −5.5% |
| Jun | 6 | 6 of 6 | +13% |
| Jul | 6 | 4 of 6 | +5.4% |
| Aug | 6 | 2 of 6 | −4.7% |
| Sep | 6 | 1 of 6 | −8.9% |
| Oct | 6 | 3 of 6 | +0.51% |
| Nov | 5 | 2 of 5 | −4.6% |
| Dec | 5 | 2 of 5 | +1.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Health Information Services
Ranks #14 of 20 by RyuScore